Similar CAR T expansion dynamics have been observed for CD19-targeting CAR T-cell agents in diffuse large B-cell lymphoma (DLBCL) and B-acute lymphoblastic leukemia (B-ALL) studies [26–29]. Here, CD19 is linked to acute lymphoblastic leukemia.